Celyad Announces February and March 2020 Conference Schedule

Nachrichtenquelle: Business Wire (engl.)
17.02.2020, 07:00  |  124   |   |   

Regulatory News:

Celyad (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that the company plans to participate at the following conferences in February and March 2020:

9th Annual SVB Leerink Global Healthcare Conference

Date:

Tuesday, February 25, 2020

Presentation time:

3:30 p.m. ET

Location:

New York, New York

Webcast:

A live and archived webcast of the presentation will be available in the Events & Webcasts section of the Celyad website

3rd Annual CAR-TCR Summit Europe

Date:

Wednesday, February 26, 2020

Time:

12:30 p.m. GMT

Location:

London, United Kingdom

27th International Molecular Med Tri-Conference

Date:

Wednesday, March 4, 2020

Presentation Time:

2:35 p.m. PT

Location:

San Francisco, California

Cambridge Healthtech Institute’s 5th Annual Immuno-Oncology Summit Europe 2020

Date:

Wednesday, March 11, 2020

Presentation time:

9:05 a.m. GMT

Location:

London, United Kingdom

BioCapital Europe 2020

Date:

Thursday, March 12, 2020

Presentation time:

3:50 p.m. CET

Location:

Amsterdam, Netherlands

VFB Congress Happening

Date:

Saturday, March 28, 2020

Presentation time:

Seite 1 von 4
CELYAD Aktie jetzt für 4€ handeln - auf Smartbroker.de



Diesen Artikel teilen
Wertpapier

Mehr zum Thema
Klicken Sie auf eines der Themen und seien Sie stets dazu informiert. Mehr Informationen hier.
EuroCapitalSECNASDAQParis


0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel